Pharma Focus Asia
KP - Sustainable Packaging Solutions

Thermo Fisher Invests US$ 50 million to Expand Bioproduction Capabilities

Thermo Fisher Scientific announced that it is investing US$50 million in its global bioproduction capabilities.


The Bioproduction capabilities will provide additional capacity for manufacturing single-use Bioprocess Container (BPC) systems.

Thermo Fisher's single-use bioprocess container systems are used for sterile liquid-handling applications.

These technologies help to increase productivity and ensure quality in the production of biological drugs.

In the UK, company is supposed to expand assembly capacity and add bioprocess container manufacturing systems. By this expansion, Europe will experience shorten leads time and improved global efficiency.

In the US, Thermo Fisher plans to expand cleanroom space for bioprocess container chambers and related assembly production processes in Logan, Utah, and also, in Millersburg, Pennsylvania.

The expansions are expected to be completed by the end of 2020.


NameThermo Fisher Scientific
LocationUK and USA
Estimated BudgetUS$50 million
ScheduleScheduled to be operational by 2020
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?